(19)
(11) EP 4 739 318 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24739483.6

(22) Date of filing: 03.07.2024
(51) International Patent Classification (IPC): 
A61K 31/538(2006.01)
 A61P 27/16(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/538; A61P 27/16
(86) International application number:
PCT/EP2024/068658
(87) International publication number:
WO 2025/008371 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 03.07.2023 EP 23306122

(71) Applicants:
  • Sensorion
    34080 Montpellier (FR)
  • Cochlear Limited
    Macquarie University, New South Wales 2109 (AU)

(72) Inventors:
  • HONNET, Géraldine
    34080 Montpellier (FR)
  • LEMOINE, Margaux
    34080 Montpellier (FR)
  • DELGADO BETANCOURT, Viviana
    34080 Montpellier (FR)
  • GAY, Robert Daniel
    Macquarie University New South Wales, 2109 (AU)
  • PLANT, Kerrie
    Macquarie University New South Wales, 2109 (AU)
  • SMYTH, Daniel
    Macquarie University New South Wales, 2109 (AU)
  • DUECK, Wolfram Frederick
    Macquarie University New South Wales, 2109 (AU)
  • GOLDMAN, Denise Rachael
    Macquarie University New South Wales, 2109 (AU)

(74) Representative: Icosa 
83 avenue Denfert-Rochereau
75014 Paris
75014 Paris (FR)

   


(54) AZASETRON FOR THE PRESERVATION OF RESIDUAL HEARING FOLLOWING COCHLEAR IMPLANTATION